LianBio
NASDAQ:LIAN
0.319 (USD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Assets: | ||||
| Current Assets: | ||||
| Cash & Cash Equivalents
| 79.221 | 228.182 | 254.35 | 43.3 |
| Short Term Investments
| 223.142 | 155.067 | 0 | 0 |
| Cash and Short Term Investments
| 302.363 | 383.249 | 254.35 | 43.3 |
| Net Receivables
| 1.77 | 6.044 | 20.261 | 0 |
| Inventory
| 0 | -6.044 | 0.97 | 0 |
| Other Current Assets
| 8.64 | 16.398 | 1.165 | 0.047 |
| Total Current Assets
| 312.773 | 399.647 | 276.746 | 43.347 |
| Non-Current Assets: | ||||
| Property, Plant & Equipment, Net
| 7.094 | 6.645 | 2.528 | 0.532 |
| Goodwill
| 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.073 | 20 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.02 | 0.051 | 0.012 | 0 |
| Total Non-Current Assets
| 7.187 | 26.696 | 2.54 | 0.532 |
| Total Assets
| 319.96 | 426.343 | 279.286 | 43.879 |
| Liabilities & Equity: | ||||
| Current Liabilities: | ||||
| Account Payables
| 1.453 | 3.231 | 4.329 | 0 |
| Short Term Debt
| 1.851 | 1.125 | 0.539 | 0.182 |
| Tax Payables
| 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 9.976 | 0.998 | 0 |
| Other Current Liabilities
| 20.311 | 0.76 | 0.36 | 3.163 |
| Total Current Liabilities
| 23.615 | 15.092 | 6.226 | 3.345 |
| Non-Current Liabilities: | ||||
| Long Term Debt
| 2.488 | 3.709 | 1.341 | 0.35 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.21 | 20.206 | 369.789 | 55 |
| Total Non-Current Liabilities
| 2.698 | 23.915 | 371.13 | 55.35 |
| Total Liabilities
| 26.313 | 39.007 | 377.356 | 58.695 |
| Equity: | ||||
| Preferred Stock
| 0 | 0 | 349.789 | 55 |
| Common Stock
| 0.002 | 0.002 | 0 | 0 |
| Retained Earnings
| -470.525 | -360.235 | -163.935 | -24.331 |
| Accumulated Other Comprehensive Income/Loss
| -2.08 | 0.526 | -0.04 | 0 |
| Other Total Stockholders Equity
| 732.476 | 713.269 | -318.657 | -46.484 |
| Total Shareholders Equity
| 259.873 | 353.562 | -132.843 | -15.815 |
| Total Equity
| 293.647 | 387.336 | -98.07 | -14.816 |
| Total Liabilities & Shareholders Equity
| 319.96 | 426.343 | 279.286 | 43.879 |